Academic History
Daneng Li, M.D., is an associate professor in the Department of Medical Oncology and Therapeutics Research at City of Hope National Medical Center in Duarte, CA, where he specializes in the treatment of gastrointestinal cancers. He is also the co-director of the Neuroendocrine Tumor Program at City of Hope National Medical Center.
Dr Li obtained his MD from Weill Cornell Medical College in New York, NY before pursuing an internship and residency in internal medicine at New York-Presbyterian Hospital/Weill Cornell Medical Center. Following this, Dr Li completed a fellowship in hematology and oncology at the Memorial Sloan-Kettering Cancer Center in New York City.
Dr Li serves on the NANETS Research Committee and the SWOG Gastrointestinal Cancer Committee, and is a member of the International Society of Geriatric Oncology as well as the Cancer and Aging Research Group. He was recently honored for his work in oncology, as a recipient of the inaugural 40 Under 40 in Cancer Award in 2018.
Speaking on novel therapeutics for liver, gastrointestinal and neuroendocrine tumors
Dr Li’s research is focused on the multidisciplinary approach to treatment of patients with neuroendocrine tumors (NETs). He leads several clinical trials focused on improving outcomes for patients with NETs and works on the development of the next generation of novel therapeutics.
